Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Angiologia ; 43(3): 93-7, 1991.
Artigo em Espanhol | MEDLINE | ID: mdl-1952258

RESUMO

During three months, 20 women, diagnosed of primary (n = 7) or secondary (n = 13) lymphoedema, were treated with hidrosmin, 400 mg t.i.d. The volume of the extremities was measured before and after therapy by projection of shadows with optoelectronic data collection; characteristics of oedema were also evaluated by means of an scoring scale including data on severity and consistency of oedema, pain, loss of function and trophic changes. The volume of the affected extremity was 2784 +/- 972 cc before treatment and was reduced to 2597 +/- 819 cc after it, the mean reduction being 5.8% +/- 9.0% (p less than 0.001). The overall scoring for clinical parameters was 4.2 +/- 1.4 before treatment and 3.5 +/- 1.5 after (p less than 0.05). The drug was well tolerated. The authors have considered hidrosmin as an important therapeutical options for the treatment of chronic lymphoedema.


Assuntos
Diosmina/análogos & derivados , Linfedema/tratamento farmacológico , Adolescente , Adulto , Idoso , Cápsulas , Criança , Doença Crônica , Diosmina/efeitos adversos , Diosmina/uso terapêutico , Avaliação de Medicamentos , Feminino , Humanos , Pessoa de Meia-Idade , Fatores de Tempo
2.
Angiologia ; 42(2): 56-8, 1990.
Artigo em Espanhol | MEDLINE | ID: mdl-2187379

RESUMO

A new method, by external pressure, analogic-digital system, is presented to be used in loco-regional treatment of "Deep Venous Thrombosis" with fibrinolytic agents; in order to allow a great concentration of drug and a better derivation of it toward the deep venous system.


Assuntos
Fibrinolíticos/uso terapêutico , Terapia Trombolítica/métodos , Tromboflebite/tratamento farmacológico , Equipamentos e Provisões , Fibrinolíticos/administração & dosagem , Humanos , Pressão
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...